Fresenius is back after three weeks for €300m 10 year

By Stefanie Linhardt
28 Jan 2014

Fresenius is back in the high yield market — after less than three weeks. The German healthcare company will this afternoon sell €300m of 10 year bonds.

Bookrunners Deutsche Bank (billing and delivering), BNP Paribas, Credit Suisse and RBS announced this morning a €200m transaction in the mid-swaps plus 205bp-225bp area.

The senior unsecured bond is rated Ba1/BB+.

With a revision of guidance, they increased the issue to €300m and set the final yield at ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Oops, something went wrong

We're sorry but at the moment we can't load this data